APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lyme Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lyme Disease Vaccine Market Analysis and Forecast 2026-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchLyme Disease Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyme Disease Vaccine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyme Disease Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lyme Disease Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lyme Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lyme Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lyme Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lyme Disease Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lyme Disease Vaccine include Merck, Zoetis and Merial, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lyme Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lyme Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Lyme Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lyme Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lyme Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lyme Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.

Lyme Disease Vaccine Segment by Company

Merck

Zoetis

Merial

Lyme Disease Vaccine Segment by Type

Inactivated Vaccine

Attenuated Vaccine

Lyme Disease Vaccine Segment by Application

Hospital

Scientific Research

Others

Lyme Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyme Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyme Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyme Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lyme Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lyme Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lyme Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lyme Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inactivated Vaccine Major Manufacturers Table 3. Attenuated Vaccine Major Manufacturers Table 4. Global Lyme Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Others Major Manufacturers Table 8. Lyme Disease Vaccine Industry Trends Table 9. Lyme Disease Vaccine Industry Drivers Table 10. Lyme Disease Vaccine Industry Opportunities and Challenges Table 11. Lyme Disease Vaccine Industry Restraints Table 12. Global Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Lyme Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Lyme Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Lyme Disease Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Lyme Disease Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Lyme Disease Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Lyme Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Lyme Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Lyme Disease Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Lyme Disease Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Lyme Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Lyme Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Lyme Disease Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Lyme Disease Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Lyme Disease Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Lyme Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Lyme Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Lyme Disease Vaccine Manufacturers, Product Type & Application Table 30. Global Lyme Disease Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Lyme Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Lyme Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Lyme Disease Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Lyme Disease Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Lyme Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Lyme Disease Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Lyme Disease Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Lyme Disease Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Lyme Disease Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Lyme Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Lyme Disease Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Lyme Disease Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Lyme Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Lyme Disease Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Lyme Disease Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Lyme Disease Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lyme Disease Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Merck Lyme Disease Vaccine Product Portfolio Table 61. Merck Recent Development Table 62. Zoetis Company Information Table 63. Zoetis Business Overview Table 64. Zoetis Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Zoetis Lyme Disease Vaccine Product Portfolio Table 66. Zoetis Recent Development Table 67. Merial Company Information Table 68. Merial Business Overview Table 69. Merial Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merial Lyme Disease Vaccine Product Portfolio Table 71. Merial Recent Development Table 72. North America Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 75. North America Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 76. North America Lyme Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Lyme Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 81. North America Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 82. North America Lyme Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Lyme Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Lyme Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Lyme Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 89. North America Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 90. North America Lyme Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Lyme Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 93. Canada Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 94. Mexico Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 95. Europe Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 98. Europe Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 99. Europe Lyme Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Lyme Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 104. Europe Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 105. Europe Lyme Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Lyme Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Lyme Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Lyme Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 112. Europe Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 113. Europe Lyme Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Lyme Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 116. France Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 117. U.K. Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Italy Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Russia Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 120. Spain Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Sweden Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Poland Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 125. China Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 126. China Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 127. China Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 128. China Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 129. China Lyme Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Lyme Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 132. China Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 133. China Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 134. China Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 135. China Lyme Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Lyme Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 140. Asia Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 141. Asia Lyme Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Lyme Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 146. Asia Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 147. Asia Lyme Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Lyme Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Lyme Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Lyme Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 154. Asia Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 155. Asia Lyme Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Lyme Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 158. South Korea Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 159. India Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 160. Australia Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Lyme Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Lyme Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Lyme Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Lyme Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Lyme Disease Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Lyme Disease Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Lyme Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Lyme Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Lyme Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Lyme Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Lyme Disease Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Lyme Disease Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Lyme Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Lyme Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Lyme Disease Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Lyme Disease Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Argentina Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Chile Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Colombia Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Peru Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Israel Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 190. UAE Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Turkey Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Iran Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Egypt Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Lyme Disease Vaccine Distributors List Table 197. Lyme Disease Vaccine Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Lyme Disease Vaccine Image Figure 2. Global Lyme Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyme Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inactivated Vaccine Image Figure 5. Attenuated Vaccine Image Figure 6. Global Lyme Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lyme Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Scientific Research Image Figure 10. Others Image Figure 11. Global Lyme Disease Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lyme Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Lyme Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Lyme Disease Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Lyme Disease Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Lyme Disease Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Lyme Disease Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Lyme Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Lyme Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Lyme Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Lyme Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Lyme Disease Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Lyme Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Lyme Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Lyme Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Lyme Disease Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Lyme Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Lyme Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Lyme Disease Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Lyme Disease Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Lyme Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Lyme Disease Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Lyme Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Lyme Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Lyme Disease Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Lyme Disease Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Lyme Disease Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Lyme Disease Vaccine Sales Share by Type (2021-2032) Figure 41. North America Lyme Disease Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Lyme Disease Vaccine Sales Share by Application (2021-2032) Figure 43. North America Lyme Disease Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Lyme Disease Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Lyme Disease Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Lyme Disease Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Lyme Disease Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Lyme Disease Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Lyme Disease Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Lyme Disease Vaccine Sales Share by Country (2021-2032) Figure 51. China Lyme Disease Vaccine Revenue Share by Type (2021-2032) Figure 52. China Lyme Disease Vaccine Sales Share by Type (2021-2032) Figure 53. China Lyme Disease Vaccine Revenue Share by Application (2021-2032) Figure 54. China Lyme Disease Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Lyme Disease Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Lyme Disease Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Lyme Disease Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Lyme Disease Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Lyme Disease Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Lyme Disease Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Lyme Disease Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Lyme Disease Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Lyme Disease Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Lyme Disease Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Lyme Disease Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Lyme Disease Vaccine Sales Share by Country (2021-2032) Figure 67. Lyme Disease Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Lyme Disease Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
Applications
  • Hospital
  • Scientific Research
  • Others
Companies covered
  • Merck
  • Zoetis
  • Merial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lyme Disease Vaccine Market by Type
  3. 1.2.1 Global Lyme Disease Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inactivated Vaccine
  5. 1.2.3 Attenuated Vaccine
  6. 1.3 Lyme Disease Vaccine Market by Application
  7. 1.3.1 Global Lyme Disease Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Scientific Research
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lyme Disease Vaccine Market Dynamics
  1. 2.1 Lyme Disease Vaccine Industry Trends
  2. 2.2 Lyme Disease Vaccine Industry Drivers
  3. 2.3 Lyme Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Lyme Disease Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lyme Disease Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lyme Disease Vaccine Revenue by Region
  3. 3.2.1 Global Lyme Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lyme Disease Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Lyme Disease Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Lyme Disease Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lyme Disease Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lyme Disease Vaccine Sales by Region
  9. 3.4.1 Global Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lyme Disease Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Lyme Disease Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Lyme Disease Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lyme Disease Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Lyme Disease Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lyme Disease Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lyme Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lyme Disease Vaccine Sales by Manufacturers
  6. 4.2.1 Global Lyme Disease Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lyme Disease Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lyme Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lyme Disease Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lyme Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lyme Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lyme Disease Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Lyme Disease Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lyme Disease Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Lyme Disease Vaccine Tier 1, Tier 2, and Tier 3
5 Lyme Disease Vaccine Market by Type
  1. 5.1 Global Lyme Disease Vaccine Revenue by Type
  2. 5.1.1 Global Lyme Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lyme Disease Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lyme Disease Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lyme Disease Vaccine Sales by Type
  6. 5.2.1 Global Lyme Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lyme Disease Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lyme Disease Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lyme Disease Vaccine Price by Type
6 Lyme Disease Vaccine Market by Application
  1. 6.1 Global Lyme Disease Vaccine Revenue by Application
  2. 6.1.1 Global Lyme Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lyme Disease Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lyme Disease Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lyme Disease Vaccine Sales by Application
  6. 6.2.1 Global Lyme Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lyme Disease Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lyme Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lyme Disease Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Lyme Disease Vaccine Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Zoetis
  8. 7.2.1 Zoetis Company Information
  9. 7.2.2 Zoetis Business Overview
  10. 7.2.3 Zoetis Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Lyme Disease Vaccine Product Portfolio
  12. 7.2.5 Zoetis Recent Developments
  13. 7.3 Merial
  14. 7.3.1 Merial Company Information
  15. 7.3.2 Merial Business Overview
  16. 7.3.3 Merial Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merial Lyme Disease Vaccine Product Portfolio
  18. 7.3.5 Merial Recent Developments
8 North America
  1. 8.1 North America Lyme Disease Vaccine Market Size by Type
  2. 8.1.1 North America Lyme Disease Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Lyme Disease Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Lyme Disease Vaccine Price by Type (2021-2032)
  5. 8.2 North America Lyme Disease Vaccine Market Size by Application
  6. 8.2.1 North America Lyme Disease Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Lyme Disease Vaccine Price by Application (2021-2032)
  9. 8.3 North America Lyme Disease Vaccine Market Size by Country
  10. 8.3.1 North America Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lyme Disease Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lyme Disease Vaccine Market Size by Type
  2. 9.1.1 Europe Lyme Disease Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lyme Disease Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Lyme Disease Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Lyme Disease Vaccine Market Size by Application
  6. 9.2.1 Europe Lyme Disease Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Lyme Disease Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Lyme Disease Vaccine Market Size by Country
  10. 9.3.1 Europe Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lyme Disease Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lyme Disease Vaccine Market Size by Type
  2. 10.1.1 China Lyme Disease Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Lyme Disease Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Lyme Disease Vaccine Price by Type (2021-2032)
  5. 10.2 China Lyme Disease Vaccine Market Size by Application
  6. 10.2.1 China Lyme Disease Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Lyme Disease Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lyme Disease Vaccine Market Size by Type
  2. 11.1.1 Asia Lyme Disease Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lyme Disease Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Lyme Disease Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Lyme Disease Vaccine Market Size by Application
  6. 11.2.1 Asia Lyme Disease Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Lyme Disease Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Lyme Disease Vaccine Market Size by Country
  10. 11.3.1 Asia Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lyme Disease Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lyme Disease Vaccine Market Size by Type
  2. 12.1.1 SAMEA Lyme Disease Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lyme Disease Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lyme Disease Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Lyme Disease Vaccine Market Size by Application
  6. 12.2.1 SAMEA Lyme Disease Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lyme Disease Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lyme Disease Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Lyme Disease Vaccine Market Size by Country
  10. 12.3.1 SAMEA Lyme Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lyme Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lyme Disease Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lyme Disease Vaccine Value Chain Analysis
  2. 13.1.1 Lyme Disease Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lyme Disease Vaccine Production Mode & Process
  6. 13.2 Lyme Disease Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lyme Disease Vaccine Distributors
  9. 13.2.3 Lyme Disease Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst